Abiopharma

News list

SATTERTHWAITE LIVINGSTON 🟢 acquired 1.3K shares (1 derivative) of Chemours Co (CC) Transaction Date: Dec 31, 2025 | Filing ID: 002824

Full text

News bot Jan. 5, 2026, 11:56 p.m.
🔍 SATTERTHWAITE LIVINGSTON (Executive)

Company: Chemours Co (CC)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,298
Detailed Transactions and Holdings:
- Acquired 1,298 shares of Deferred Stock Units (Derivative)
  Date: 2025-12-31 | Code: A | equity_swap_involved: false | shares_owned_after: 4,615.31 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
Footnotes:
- F1: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director.
- F2: Includes deferred stock units and dividend equivalent units.